Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Expanded Carrier Screening Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market for expanded carrier screening has experienced substantial expansion recently, with projections indicating continued strong growth. This sector is anticipated to advance from a valuation of $2.46 billion in 2025 to $2.87 billion by 2026, reflecting a compound annual growth rate of 16.7%. Factors contributing to this upward trajectory during the past period include heightened consciousness regarding hereditary genetic conditions, the broader implementation of prenatal screening initiatives, enhancements in the precision of genetic sequencing technologies, augmented accessibility to diagnostic testing facilities, and an increasing trend among healthcare professionals to incorporate carrier screening methodologies into their practices.

The expanded carrier screening market is poised for substantial expansion in the coming years, projecting a rise to $5.28 billion by 2030, driven by a compound annual growth rate of 16.4%. This accelerated growth during the forecast period is anticipated to be fueled by several key factors, including a growing appetite for individualized reproductive health approaches, the escalating incorporation of AI for interpreting genetic variations, the broader implementation of screening programs across entire populations, increased capital flowing into genomic data infrastructure, and a heightened emphasis on proactive genetic wellness. Key developments shaping this market in the upcoming years are expected to involve greater acceptance of comprehensive genetic screening panels applicable to diverse ethnic backgrounds, a surge in the need for carrier testing prior to conception, the wider utilization of advanced next-generation sequencing techniques, the growth of genetic testing services delivered directly to healthcare providers, and a more pronounced integration of genetic counseling services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28215&type=smp

Expanded Carrier Screening Market Growth Drivers And Industry Catalysts

The expanding market for expanded carrier screening is poised for growth, largely fueled by the increasing incidence of genetic conditions. These inherited or spontaneously occurring conditions stem from alterations or defects within an individual’s genetic makeup. The heightened detection of genetic diseases is attributable to sophisticated diagnostic technologies, especially next-generation sequencing and other genomic instruments, which have markedly enhanced the capacity to diagnose a broad spectrum of genetic abnormalities that were once overlooked or misidentified. Expanded carrier screening plays a crucial role by identifying individuals who carry genetic disorders before the onset of symptoms, thereby facilitating informed family planning choices and mitigating the transmission of heritable ailments to subsequent generations. As an illustration, data from the Cystic Fibrosis Trust indicated that in 2022, there were 11,148 individuals registered with cystic fibrosis in the UK, a figure that subsequently rose to 11,318 in 2023, signifying a year-on-year increment of 1.5% in patient registrations. Consequently, the escalating occurrence of genetic diseases is a primary catalyst for the expansion of the carrier screening market.

Expanded Carrier Screening Market Segment Landscape: Which Areas Lead Market Development?

The expanded carrier screening market covered in this report is segmented –

1) By Type: Customized Panel Testing, Predesigned Panel Testing

2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

3) By Application: Preconception, Prenatal, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users

Subsegments:

1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels

2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels

#Expanded Carrier Screening Market Trends Influencing Long-Term Demand

Leading participants in the growing carrier screening sector are prioritizing the creation of novel approaches, exemplified by integrated next-generation sequencing-based panels, which enable the identification of diverse genetic ailments with enhanced precision and efficacy. These advanced NGS panels function as sophisticated genetic assessments, simultaneously examining numerous genes to pinpoint a broad array of hereditary diseases with remarkable speed and accuracy. To illustrate, Fulgent Genetics Inc., a prominent US genomic testing firm, introduced its Beacon787 Expanded Carrier Screening Panel in February 2023, a product engineered to scrutinize 787 genes associated with serious inherited health issues. This particular panel boasts extensive scrutiny of more than 700 autosomal recessive and X-linked conditions, encompassing all Tier 3 genes, and capitalizes on cutting edge next-generation sequencing technology. This technology affords superior analytical precision, a universally applicable ethnic approach, and a rapid 2 to 3 week turnaround, establishing it as a premier, highly accurate option for reproductive carrier screening.

Expanded Carrier Screening Market Industry Leaders And Market Competition

Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech

Access The Complete Expanded Carrier Screening Market Report:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

Expanded Carrier Screening Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the expanded carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the expanded carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model